Technologies to deliver therapeutics across the blood brain barrier - a common barrier that impedes the treatment of many brain diseases. Technologies to help optimize therapies that are most likely to benefit selected patients - commonly known as personalized medicine. Molecularly targeted therapies that affect the abnormal pathways implicated in a variety of brain related disorders.